CG
ACOR

Cutler Group’s Acorda Therapeutics ACOR Stock Holding History

Cutler Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed – – 6405
2021
Q3 		$0 Hold
6
– – ﹤0.01% 6611
2021
Q2 		$0 Hold
6
– – ﹤0.01% 6600
2021
Q1 		$0 Hold
6
– – ﹤0.01% 6524
2020
Q4 		$0 Hold
6
– – ﹤0.01% 5695
2020
Q3 		$0 Hold
6
– – ﹤0.01% 5410
2020
Q2 		$0 Hold
6
– – ﹤0.01% 5064
2020
Q1 		$0 Hold
6
– – ﹤0.01% 4865
2019
Q4 		$1K Hold
6
– – ﹤0.01% 3833
2019
Q3 		$2K Hold
6
– – ﹤0.01% 3601
2019
Q2 		$5K Hold
6
– – ﹤0.01% 3155
2019
Q1 		$9K Hold
6
– – ﹤0.01% 2595
2018
Q4 		$10K Sell
6
-1
-14% -$2.18K ﹤0.01% 2556
2018
Q3 		$15K Buy
7
+2
+40% +$6.19K ﹤0.01% 2431
2018
Q2 		$17K Sell
5
-47
-90% -$144K ﹤0.01% 2318
2018
Q1 		$147K Buy
52
+35
+206% +$105K 0.01% 973
2017
Q4 		$42K Sell
17
-74
-81% -$210K ﹤0.01% 2012
2017
Q3 		$257K Buy
91
+50
+122% +$132K 0.01% 1017
2017
Q2 		$96K Sell
41
-81
-66% -$160K ﹤0.01% 1895
2017
Q1 		$306K Buy
122
+10
+9% +$28.8K 0.01% 897
2016
Q4 		$251K Buy
112
+36
+47% +$85.6K 0.01% 1139
2016
Q3 		$190K Buy
76
+51
+204% +$152K 0.01% 1266
2016
Q2 		$77K Sell
25
-115
-82% -$374K ﹤0.01% 1939
2016
Q1 		$444K Buy
140
+131
+1,456% +$544K 0.03% 576
2015
Q4 		$47K Buy
+9
New +$39.3K ﹤0.01% 2541

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's ACOR Position: Q4 2021 in Review

Cutler Group sold out of Acorda Therapeutics (ACOR) in Q4 2021, closing a stake of 6 shares.

Cutler Group first reported a position in ACOR in Q4 2015 and held it in 24 quarters. The position peaked at $444K in Q1 2016. 32 funds tracked by Wall St. Rank hold ACOR as of Q4 2021.

  • Cutler Group reported no remaining Acorda Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 6 Acorda Therapeutics shares in Q4 2021.
  • Cutler Group first reported a position in Acorda Therapeutics in Q4 2015 and held it in 24 quarters.
  • Cutler Group's Acorda Therapeutics position peaked at $444K in Q1 2016.
  • 32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.